Neurocenter Finland pilot projects enhance national cooperation in neuroscience research
In a preparatory phase in 2018, the Ministry of Social Affairs and Health granted Neurocenter Finland EUR 900,000 in state aid for pilot projects in clinical research and treatment as well as for preparing an operating concept for Neurocenter Finland. A bundle of six pilot projects will strengthen the cooperation between basic research and patient […]
Finnadvance’s organ-on-chip technology can be used to model human organ tissues
Oulu-based Finnadvance is developing organ-on-chip devices that have great potential in drug development. Experts from Neurocenter Finland have helped the company’s path to growth. Organ-on-chip is an elegant biotechnology device utilizing microfluidic technology, in which human cells are grown and form structures similar to the real organ structures. In the credit card-sized chip, cells can […]
Update on the Functional Brain Imaging Biobank Pilot Project
For many diseases of the brain, particularly various kinds of dementia, early-stage diagnosis is usually challenging because of the lack of accurate, objective diagnostic tools. To improve this situation, Aalto University, together with the Universities of Helsinki, Oulu, Turku, and Tampere, as well as Finland’s university hospitals, decided to establish a national network for collecting […]
Happy World MS Day!
World MS Day is celebrated on 30.05. Pioneering interdisciplinary work on multiple sclerosis (MS) is being carried out in pilot project coordinated by Neurocenter Finland, which have brought together excellence from various fields. Neurocenter Finland is coordinating a project focusing on MS, consisting of two different entities. It is one of the six pilot projects […]
Save the Date: BrainBreak meetings
BrainBreaks are regularly organized, relaxed afternoon coffee breaks especially for the neuroresearchers, but also for other operators interested in brain health. The main aim is to offer networking possibilities for both pre-clinical and clinical researchers with as wide range as possible. BrainBreaks will be organized online or as “hybrid” meetings (both face to face and […]
Potential breakthrough in the treatment of Parkinson’s disease – drug candidate CDNF could stop the progression of the disease and improve symptoms
The novel drug candidate CDNF, discovered at the Institute of Biotechnology, University of Helsinki, could be a disease-modifying treatment of Parkinson’s disease in addition to alleviating its symptoms. Such a breakthrough would also have significant social implications. In Finland, approximately 14 000 patients suffer from Parkinson’s disease, and thus far, there is neither a cure […]